BF9, the first functionally characterized snake toxin peptide with Kunitz-type protease and potassium channel inhibiting properties.
about
Strong and widespread action of site-specific positive selection in the snake venom Kunitz/BPTI protein familyToxin acidic residue evolutionary function-guided design of de novo peptide drugs for the immunotherapeutic target, the Kv1.3 channel.Toxins Targeting the Kv1.3 Channel: Potential Immunomodulators for Autoimmune DiseasesTreating autoimmune disorders with venom-derived peptides.
P2860
BF9, the first functionally characterized snake toxin peptide with Kunitz-type protease and potassium channel inhibiting properties.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
BF9, the first functionally ch ...... channel inhibiting properties.
@en
BF9, the first functionally ch ...... channel inhibiting properties.
@nl
type
label
BF9, the first functionally ch ...... channel inhibiting properties.
@en
BF9, the first functionally ch ...... channel inhibiting properties.
@nl
prefLabel
BF9, the first functionally ch ...... channel inhibiting properties.
@en
BF9, the first functionally ch ...... channel inhibiting properties.
@nl
P2093
P2860
P356
P1476
BF9, the first functionally ch ...... channel inhibiting properties.
@en
P2093
Weishan Yang
Yingliang Wu
Zhijian Cao
Zongyun Chen
P2860
P356
10.1002/JBT.21538
P577
2013-11-14T00:00:00Z